Study Title: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Dominick, Anthony, at dominica@musc.edu.Study Coordinator, Bryan, Emma, at bryane@musc.edu.Trial opened at the following institutions: Medical University of South Carolina